Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) just unveiled an announcement.
WuXi AppTec Co., Ltd. has revised the terms of reference for its Audit Committee to enhance the Board of Directors’ efficiency and strengthen its audit and supervision functions. The Audit Committee is tasked with coordinating and evaluating internal and external audits, reviewing financial disclosures, and supervising major decisions, ensuring effective internal control and accurate financial reporting. This initiative is expected to improve the company’s governance and operational transparency, benefiting stakeholders by ensuring compliance with relevant regulations.
The most recent analyst rating on (HK:2359) stock is a Buy with a HK$133.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. operates in the pharmaceutical and biotechnology industry, providing a broad range of services including research, development, and manufacturing support for pharmaceutical, biotechnology, and medical device companies. The company focuses on enabling its clients to advance discoveries and deliver new treatments to patients.
Average Trading Volume: 9,084,704
Technical Sentiment Signal: Buy
Current Market Cap: HK$323.9B
See more data about 2359 stock on TipRanks’ Stock Analysis page.